Cutaneous adverse drug reaction profile in a tertiary care out patient setting in Eastern India

Indian Journal of Pharmacology

Volumn 44, Issue 6, 2012, Pages 792-797

  Saha, Abanti ^a   Das, Nilay Kanti ^a   Hazra, Avijit ^b   Gharami, Ramesh Chandra ^a   Chowdhury, Satyendra Nath ^a   Datta, Pijush Kanti ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Causality assessment; cutaneous adverse drug reaction; dermatologic pharmacology; pharmacovigilance

Indexed keywords

ALLOPURINOL; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ATORVASTATIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CIPROFLOXACIN; COTRIMOXAZOLE; LAMOTRIGINE; MACROLIDE; METHOTREXATE; METRONIDAZOLE; NITROIMIDAZOLE; NORFLOXACIN; OFLOXACIN; ORNIDAZOLE; PARACETAMOL; PHENYTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALAZOSULFAPYRIDINE; SULFONAMIDE; SULFONE; THIAZIDE DIURETIC AGENT; TINIDAZOLE; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; DERMATOLOGY; DRUG ERUPTION; DRUG INDUCED DISEASE; ERYTHRODERMA; FEMALE; HUMAN; INCIDENCE; INDIA; MALE; MEASLES LIKE RASH; MUCOSA INFLAMMATION; OBSERVATIONAL STUDY; PHOTOTOXICITY; PITYRIASIS ROSEA; SKIN DEFECT; STEVENS JOHNSON SYNDROME; TERTIARY HEALTH CARE; URTICARIA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG ERUPTIONS; DRUG TOXICITY; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; OUTPATIENTS; PHARMACEUTICAL PREPARATIONS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84870026988     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.103304     Document Type: Article

References (18)

1. Nayak S, Acharjya B. Adverse cutaneous drug reaction. Indian J Dermatol 2008;53:2-8.
2. Sengupta SR, Das NK. Cutaneous adverse drug reaction to systemic drugs: Recent updates. In: Ghosh S, editor. Recent Advances in Dermatology. 1st ed. New Delhi: Jaypee Brothers Medical Publishers; 2004. p. 88-114.
3. The use of the WHO-UMC system for standardized case causality assessment [monograph on the Internet]. Uppsala: The Uppsala Monitoring Centre; 2005. Available from: http://www.who-umc.org/graphics/4409.pdf. [Last accessed 2010 Apr. 7].
4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18, 820 patients. BMJ 2004;329:15-9.
5. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001;53:357-79.
6. Chatterjee S, Ghosh AP, Barbhuiya J, Dey SK. Adverse cutaneous drug reactions: A one year survey at a dermatology outpatient clinic of a tertiary care hospital. Indian J Pharmacol 2006;38:429-31.
7. Ghosh S, Acharya LD, Rao PG. Study and evaluation of various cutaneous adverse drug reaction in Kasturaba Hospital, Manipal. Indian J Pharm Sci 2006;68:212-5.
8. Borch JE, Andersen KE, Bindslev-Jensen C. The prevalence of acute cutaneous drug reactions in a Scandinavian university hospital. Acta Derm Venereol 2006;86:518-22.
9. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents - a 6 year series from Chandigarh, India. J Postgrad Med 2001;47:95-9.
10. Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008;74:430-3.
11. Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care centre in South India. Indian J Dermatol Venereol Leprol 2004;70:20-4.
12. Puavilai S, Timpatanapong P. Prospective study of cutaneous drug reactions. J Med Assoc Thai 1989;72:167-71.
13. Kacalak-Rzepka A, Klimowicz A, Bielecka-Grzela S, Załuga E, Maleszka R, Fabiañczyk H. Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006. Ann Acad Med Stetin 2008;54:52-8.
14. Sharma VK, Dhar S. Clinical pattern of cutaneous drug eruption among children and adolescents in north India. Pediatr Dermatol 1995;12:178-83.
15. Hede SS, Diniz RS, Agshikar NV, Dhume VG. Pattern of prescribed and OTC drugs in north Goa. Indian J Pharmacol 1987;19:145-8.
16. Sushma M, Noel MV, Ritika MC, James J, Guido S. Cutaneous adverse drug reactions: A 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf 2005;14:567-70.
17. Jhaj R, Uppal R, Malhotra S, Bhargava VK. Cutaneous adverse reactions in in-patients in a tertiary care hospital. Indian J Dermatol Venereol Leprol 1999;65:14-7.
18. Hunziker T, Künzi UP, Braunschweig S, Zehnder D, Hoigné R. Comprehensive hospital drug monitoring (CHDM): Adverse skin reactions, a 20-year survey. Allergy 1997;52:388-93.